Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease,
affecting approximately one-quarter of the global population, and has become a world public …

Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

Background Nonalcoholic steatohepatitis (NASH) is a common disease that is associated
with increased morbidity and mortality, but treatment options are limited. The efficacy and …

The obesity epidemic is closely associated with the rising prevalence and severity of
nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple …

An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver
disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis …

Due to the rising prevalence of obesity and type II diabetes mellitus, non‐alcoholic fatty liver
disease is becoming the leading cause of chronic liver disease in the Western world. In …

НЕАЛКОГОЛЬНАЯ ЖИРОВАЯ БОЛЕЗНЬ ПЕЧЕНИ У ВЗРОСЛЫХ: КЛИНИКА,
ДИАГНОСТИКА, ЛЕЧЕНИЕ.РЕКОМЕНДАЦИИ ДЛЯ ТЕРАПЕВТОВ, ТРЕТЬЯ ВЕРСИЯ …

Chronic liver disease (CLD), manifested as hepatic injury, is a major cause of global
morbidity and mortality. CLD progresses to fibrosis, cirrhosis, and—ultimately …

Background The prevalence of non-alcoholic fatty liver disease (NAFLD) has been
increasing rapidly. It is nowadays recognized as the most frequent liver disease, affecting a …